Bright Minds Biosciences Inc. (DRUG) Financials

DRUG Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 5.2 million 643992
2023-09-30 5.1 million 206656
2023-06-30 6.4 million 555076
2023-03-31 7.4 million 769096

DRUG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -619811 165076
2023-09-30 -881147 294688
2023-06-30 -1.2 million 179433
2023-03-31 -1.1 million 22141

DRUG Net Income

No data available :(

DRUG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 5.1 million - 41137
2023-09-30 5.0 million - 54117
2023-06-30 6.1 million - 69049
2023-03-31 7.1 million - 80065

DRUG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.9 million
2023-09-30 2.7 million
2023-06-30 2.8 million
2023-03-31 2.8 million

DRUG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 923982 274875 27594
2023-09-30 - 802998 310926 26930
2023-06-30 - 793686 259271 28025
2023-03-31 - 1.0 million 412437 3436

DRUG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 13656
2023-09-30 - 13326
2023-06-30 - 13682
2023-03-31 - 13388

DRUG

Price: $1.05

52 week price:
0.97
6.44

Earnings Per Share: -1.21 USD

P/E Ratio: -1.30

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 141500

Market Capitalization: 5.8 million

Links: